Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22168545 | 0.91 | THRB (0.35) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL22168539 | 0.66 | THRB (0.40) | HIF1ATHRBTSHRPOLBAPEX1 | |
| Ammonia Solution, Strong SCHEMBL28236453 | 0.63 | TSHR (0.55) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL12126365 | 0.63 | THRB (0.52) | CHRM1TBXA2RADRA1ATHRBTSHR | |
| SCHEMBL12017797 | 0.63 | THRB (0.52) | CHRM1THRBTSHRPOLBAPEX1 | |
| SCHEMBL12196883 | 0.63 | POLB (0.49) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL5030578 | 0.62 | TDP1 (0.46) | CYP2C9THRBTSHRPOLBAPEX1 | |
| SCHEMBL1652027 | 0.62 | THRB (0.64) | CHRM1CYP1A2HIF1ATHRBTSHR | |
| SCHEMBL260320 | 0.62 | THRB (0.50) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL16573569 | 0.62 | THRB (0.50) | THRBTSHRPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200209747-A1 | POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200209747-A1 | POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS | INSR, INSRR, ZFR | LMNA 1042/4885CYP2C9 4856/4885CHRM1 4318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.